![Andrew Wang, MD, is a UNC Lineberger member and associate professor in the UNC School of Medicine Department of Radiation Oncology and UNC Eshelman School of Pharmacy..](https://unclineberger.org/wp-content/uploads/sites/867/2018/10/nanoparticle-bone-loss-image2-427x400.jpeg)
January 26, 2016
Nanoparticle form of bone loss prevention drug effective against cancer, preclinical study finds
A preclinical study led by a UNC Lineberger researcher found that a nanoparticle form of a drug used to prevent bone loss was effective against small-cell lung and prostate cancer cells. The results were published in the journal Biomaterials.